BioRem Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CAD 28.86 million compared to CAD 24.48 million a year ago. Net income was CAD 1.61 million compared to CAD 1.3 million a year ago.

Basic earnings per share from continuing operations was CAD 0.1 compared to CAD 0.04 a year ago. Diluted earnings per share from continuing operations was CAD 0.09 compared to CAD 0.04 a year ago.